ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000946.1|Vibrioferrin_1 # 283 # 1494 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.496	BGC0000946.1|Vibrioferrin_1 	283	1494	+	Loose	350	41.9726	vanF	29.05	3002908	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAAATCTACGATGATTATCGTAAGTCATGTCGTTAATGATGCAGTCACTCACGGCTTCGTGCCTGCAGCTAAAGCGATGGACCTCCACGTCGTTCTTATCACCGATCACAAGCTCAGCCATTTAGAACTGGCAAGTCGTGATAGTCACTTTAATCCGGATGCCATTCTAGAGTGCGATGTCTTCAATCCCTTGGAGATCATCGAAACCATCACTGAGAATGAGTTAAAACCCGACGCTATTTTCAGCAATAGTGATCACTTACAAACTTCCACCGCCATATGCGCACAATTTTTTGGTCTACCGGCCAAAGATTGGTCTGTCACGTTAAAGGCCAAAAACAAACACTTAACTCGACAAGTGTTGAATGAAAAAGCCCTACCCAACACACAAAGCTGTTTGTTGCACCGCCATTCGAATGTGGCATTAGGCATGGCCTTCCCTGTCGTAGCAAAACCCAAAGAAGGCGTGGCGAGTTTGGATGTGCAGCGCTGTGACTCCCAAAGCGAGCTCGACGCATACTGCGATGCATTTTGGCAAAACTACCCAAACACCGCCATTCTGGTGGAGCAGTTCCTTCAAGGGCCTTTGGTTACGCTCGAAACTCTGGGAGATGGTGAGCGCCTTATCGCCGTCGGCGGTTTTGATGTGTCGCTCTCTGAGCCGCCTTACTTTATCGAAACAGCCGCAGACTGGAACGGACCAAACGGCATTGCTCACCGAGAAGCGTGCTTGGCTCAACTGAAAGCGTTCGGCGTTGGTTTTGGAGTTTGCCACAGCGAATTTATCATCACGGAAAACGGCCCAGTTCTGGTGGAAATTAACTACCGCAGCATTGGGGACGGTCGCGAATTCTTGCTCAACAATCTCGCTCACTTCGGTTGGTTTAGCACAATTTTAGGTCTGCATTTGGGCCGAAGATTGGATGGCGATTACCAAATTCATGGCTCAGCACACGTGCACTATGTGGTTGCGGAGCACAGTGGTGTGATTGATGGAGATTCGACCTCCTTCATCCAACACGATGGCGATGTCATCACCCAGCAACAGGTACTAAAAACCGCGGGAGAACTCTTCCAACAGAGTTATTCCAACAAGGATTATCTCGCCCGAATTTCGATTGTCTCGCCATCGGGGCGAAACCTCGACCAAGCGCTGCAGAACGCGCTTAGCAATTTCAATCTAGCTCCGACTCGCGAGGTGGCAGCATGA	MKSTMIIVSHVVNDAVTHGFVPAAKAMDLHVVLITDHKLSHLELASRDSHFNPDAILECDVFNPLEIIETITENELKPDAIFSNSDHLQTSTAICAQFFGLPAKDWSVTLKAKNKHLTRQVLNEKALPNTQSCLLHRHSNVALGMAFPVVAKPKEGVASLDVQRCDSQSELDAYCDAFWQNYPNTAILVEQFLQGPLVTLETLGDGERLIAVGGFDVSLSEPPYFIETAADWNGPNGIAHREACLAQLKAFGVGFGVCHSEFIITENGPVLVEINYRSIGDGREFLLNNLAHFGWFSTILGLHLGRRLDGDYQIHGSAHVHYVVAEHSGVIDGDSTSFIQHDGDVITQQQVLKTAGELFQQSYSNKDYLARISIVSPSGRNLDQALQNALSNFNLAPTREVAA	MNRLKIAILFGGCSEEHDVSVKSAKEIANNIDTEKYEPIYIGITRSGVWKMCEKPCMDWDNENCRSAVLSPDKKMHGLLVMRNKGYQIQRIDAVFSVLHGKSGEDGAIQGLFELSSIPYVGCDVQSSAVCMDKSLTYIVAQNAGFGTPEFLILNHGDIPDSNTLTYPVFVKPARSGSSFGVNKVNNEDELDAAIETARQYDSKVLIEQAVPGLEVGCAVLGNGTDLIVGEVDQISLSHGIFRIHQEDQPEKGSENAVVLVPANLSAEKRIKIQETAKAIYKALGCKGLSRVDMFLQENGRIILNEVNTLPGFTAYSRYPRMMAAAGMTLSGLIDHCITLALKG	117.49	gnl|BL_ORD_ID|1612|hsp_num:0	1759			489	921	vancomycin
BGC0000946.1|Vibrioferrin_2 # 1491 # 3323 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.501	BGC0000946.1|Vibrioferrin_2 	1491	3323	+	Loose	500	26.1794	OXA-9	52.38	3001404	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAATCACAACGCTTTATACCTAACCCAACGATTGAACGATACTTGCCTGCGCGAAGACATGTTTGGCATTTTATCGAACGCCAAGTTCAGTAGCGCCGCACCAAAAGGGGTTATTGTTCCTCAAAGCGAGCAAGTCTGGCTGACCTTTGATAATCCGGATCTCACGCTCTATTTACCTGTTGTGCCAACGTATTACATGCAGCATTGGTGTTACGGCCAAGCCAATGGCGAACGGCCACTAGGTTGGTGGGTGGAGAAAAATGGCCAAGTCGAGCATCAGCAGCATTATCAAGAGTGGATTGCGCTACTAACGACACTGGCGCATGAGAGCTCTCACGAATTGTTGGCGGGGTATCTTCAAGAACTGGAATGCGCAGAGAAACACAAAGCACTGTGTGACCAAGCGTTTCGTCACCACGCCGACCACATTTCTCAACCAATATCCAAGCTTGGCTCTTGGCATCAAAAACTGCTGCTTGCTGACCAGATCGCTTCTTACCTTGACCACCCGTACTATCCAACTGCGCGGGCGAAGTTTGGTCTGAGCGATGAAGACCTTGCTAAGTACGCGCCCGAGTTCGCACAAAGCTTTGCTCTGCATTGGATTGCGATTGAAAAATCACTGGTGACATTAACCAGCGAACAACCTGATTGCTGGCCAACAATAGAGCAAGTGGGGCTTCCTGCTGACTTTGCACTGAGCCACGTACTGTTCCCTGCGCATCCGCTCACCCTTCGCTCTTTAGAAGCCTTACCCGAAGGCATGATAGAAGCGCCGTTTACGTACCTAGACGTGACGCCAACACTTTCCGTTCGTACTGTGGTAGTCAACGACGCGCCGCACATTCACATCAAAGTTCCGCTGATCATGCGATCGCTAGGCACGAAAAACATTCGCTTAATCAAGCCTTCAACACTGTATGACGGCCACTGGTTTGAACGTCTACTCAGCCACCTTGAACAAACGGACGCCGACTTAAACAGTCGCTTGTTCCATTGCAACGAAAAACACGGTGGACACGTCGGTGAGGATAAAACCTTCGCGTACATCGTACGTGAGTACCCACTTACCCATTGCGAAGACAAAGCGTTAGTTCCGGTTGCCGCACTGGCAAGCCCAATGCCTGACGGTCGCTTGTTTTTAGAACATTTGGCGGAGCAGTACTATCAACAAGATACGCTGGCGTGGTTCAAAGATTACGTCGACCTATTATGCCAAGTACACCTCACCTTGTGGCTTCGTTATGGCATCGCATTGGAGTCCAACCAGCAAAACGCCATCGTTGCATTTGATCAACAGGGCAAAATGACGCTCGCGATGAAAGACAACGACGCGGCGCGAATTTGGCCAGAGCGCTTCCACTTTGCAACAGAGCATGCTGCCCAAAAACACGGCGCAGGAACAAATCCCGTGGATTGTGATGAACTGCTCGACCAACGCATCAAAGTCGACAATGAATTGGCGCTCGGTCAGATGTTTACCACCATCACATTACAACTGGATATTGCAGCGATTGTAGAAGCCATGGCAGCGAAGTGCATTGCCTCTTCAGCATCGCTTTACGCCATCGTGGCCAAAAGCATTGCAGAGCAACTCAACCGATTGGAAGGCGAAGGGTTAGAGACAAAACTGGCACGCGAGTTACTGCAAGAAGCACCTGATTTGTACGCCAAGTACTTGTTGAGCTCTGGCAGTTTGCTCTCGAAAGATGCCTCCGGCGCGAGCGACATCAATAAGTTCTATGGTTTGTCGGCTCCGAACTTCTTGCTGCTTTCTAGCGAAGAAGCGCAACGCGCCTACTTAGAAGCCATCAAAAAAAGCGTACGTTAA	MNHNALYLTQRLNDTCLREDMFGILSNAKFSSAAPKGVIVPQSEQVWLTFDNPDLTLYLPVVPTYYMQHWCYGQANGERPLGWWVEKNGQVEHQQHYQEWIALLTTLAHESSHELLAGYLQELECAEKHKALCDQAFRHHADHISQPISKLGSWHQKLLLADQIASYLDHPYYPTARAKFGLSDEDLAKYAPEFAQSFALHWIAIEKSLVTLTSEQPDCWPTIEQVGLPADFALSHVLFPAHPLTLRSLEALPEGMIEAPFTYLDVTPTLSVRTVVVNDAPHIHIKVPLIMRSLGTKNIRLIKPSTLYDGHWFERLLSHLEQTDADLNSRLFHCNEKHGGHVGEDKTFAYIVREYPLTHCEDKALVPVAALASPMPDGRLFLEHLAEQYYQQDTLAWFKDYVDLLCQVHLTLWLRYGIALESNQQNAIVAFDQQGKMTLAMKDNDAARIWPERFHFATEHAAQKHGAGTNPVDCDELLDQRIKVDNELALGQMFTTITLQLDIAAIVEAMAAKCIASSASLYAIVAKSIAEQLNRLEGEGLETKLARELLQEAPDLYAKYLLSSGSLLSKDASGASDINKFYGLSAPNFLLLSSEEAQRAYLEAIKKSVR	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK	222.63	gnl|BL_ORD_ID|219|hsp_num:0	243			648	711	cloxacillin; oxacillin; cefalotin
BGC0000946.1|Vibrioferrin_3 # 3330 # 4535 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000946.1|Vibrioferrin_3 	3330	4535	+	Loose	700	67.3958	mdtG	23.87	3001329	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCAAACTCATCTACAGTGTGTTGTTGTGCCACTTTATCGCTGCGTTTGCCGCGTTAGGTATGCCGCTATTTCTACCCGTCGTGTTGCCAACGTTAGGCGCAAGCATTGATGCGGACTGGGCAGGGGTATTGTTTATCCTACCCACGTTTTGTACTGCGTTGGCGGCGCGATTTTGGGGCAACTTTGCCGATCGCTACGGTCGCCGCCGCTCACTCTTGCGTGCACAACTTGGCCTTGCAGCAGGGTTTGCGCTGTGCGGCTTGGCAGACAACCTCGCCATGTTTGTGTTTGGTCTTATTGTTCAAGGAACCTTTGGCGGCACCATGGCCGCCTCGAACAGCTACTTATCTAGTCAAATTAAAGAAGCCAAAACACTCGGCAAGTCACTCAATAAAACCCAACTATCTGCTCGCTTGGCGCTGATCGTTGCACCCATTGGGCTCGGCTGGAGCTTGTCCGAAACCAACCCGCTCAACGCGTACCTGTGGTTATGCGTTTTGCCTTTAATTGCGATGGGCATCACGCTAACACTGCCAGCGGATAAACCCGCCGAACAAAACCTCGAAAAGCCAAACTCAGAATCTCAGCAAGAACAACCTGTTGCAAAGAAAAACGCAATGCATGCCATTCGTTGGATCTTCTTTGCTCAGTTCGGGTTTGCGTTTTCTATGGTGGTGACCTTTCCTTATTTCTCGCCGTTTGTGCAGCAATATGGCATCACTAACCACGCATGGATCGGTTTTTTGTACGCACTGCCGCATGGCGTCTATCTGTTGCTGGCAGGCAAAATCCACGTGTTGTCAGATGGGCTGAATCGCCATCAAACCGTGCGCACGTTGTGGCTCGGGTTTGCATTGCTTGCCGTGAGCTCTGCCTTGCATTTGATTGCGTCCGAAATCGCACTCATTGCTGCGAGAATTATCTTCGGCATCGCGATGGTGTGTTGCTATCACGGATTGCATCAGCATCTTGCGAGCAATCTGGATCGCAAACTCAGTGGCAAAGTATTTTCTCGCTTTGATGCCATGTCCAAATGGGGTGGCGTGGCGGCGGGATTTTGCGCTTCTTTCATTTCTAGCTTGGGGCTACTTGAGGTTCCTTTCCTACTTTCTGCGATAGTCAGCGTAATCACCTTGATCGCGCTGGTTCTCCACTCAAAATTTGGAAATCAACATGTTACAAACTCAATCCTCTCAGACTAG	MTKLIYSVLLCHFIAAFAALGMPLFLPVVLPTLGASIDADWAGVLFILPTFCTALAARFWGNFADRYGRRRSLLRAQLGLAAGFALCGLADNLAMFVFGLIVQGTFGGTMAASNSYLSSQIKEAKTLGKSLNKTQLSARLALIVAPIGLGWSLSETNPLNAYLWLCVLPLIAMGITLTLPADKPAEQNLEKPNSESQQEQPVAKKNAMHAIRWIFFAQFGFAFSMVVTFPYFSPFVQQYGITNHAWIGFLYALPHGVYLLLAGKIHVLSDGLNRHQTVRTLWLGFALLAVSSALHLIASEIALIAARIIFGIAMVCCYHGLHQHLASNLDRKLSGKVFSRFDAMSKWGGVAAGFCASFISSLGLLEVPFLLSAIVSVITLIALVLHSKFGNQHVTNSILSD	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	98.28	gnl|BL_ORD_ID|550|hsp_num:0	603			42	1152	fosfomycin
BGC0000946.1|Vibrioferrin_4 # 4507 # 6336 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.492	BGC0000946.1|Vibrioferrin_4 	4507	6336	+	Loose	400	27.7202	ErmB	36.11	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTTACAAACTCAATCCTCTCAGACTAGCGAGTTGCGCGCGCATGATGTGCAGCTCAATCGTGAGAAAGCCCAACTCAACACGATAATGGGTGTTCTTAATTGTTACTTACGTGAATTTGCACTGCCGAATCAACAAGTGGAATGGCACTACCAATCGACATCGCTACCCCAAACGTTAAAACGCAACTATTCCGCCAAGCAGCGGGTAGCCGTTCATCTGTCTCAACAAAATGGCGTGCTGGTTTTGCCGATTCACTACGCGAGCAAACTGGGCAAAATCAAATTGGCAGAACTGCCGTGGGCGAAAATGCCGGGATCTGGTTGGGCGAAATTGGATGCCACGCAAACTCTTACGCTTTTGCTTAACTATCTCAAGCAGGTGTTGGCGATCCCGTTCAACCATGAGCTGATCGAACAACTGGAAAATAGCGTGCTGGTTACCGAGCAGTTTCTCAACGTCGCGTCCAAATCGCATCACAACGAATTTATCGCTTCGGAACAATCACTGATTTGGGGACATACTTTCCATCCGACCCCGAAAAGTCGTTCGGGCGTCACCATGGATGATCTCTTGGCGTTTTCTCCAGAAGTCGGCGCGCAAGTCCCGTTGTACTGGTTTGAAGTGGATACGTCCTTACTTGATGTGCTGAATTCAGACGGAGACGCTAACCCTGCGCAACGCATGCTACAACAGCTCGCGCCACAACACGCCACCAGCAATGGGAAGACCCTCTACCCTTGCCATCCTTGGGAAAGCTACACCATTTTGAGCAACCCAAGCGTGAAGGCTCCCATTGAACAAGGCAAAATCACGCCACTGGGTTTAGGTGGTGAAAAGATGCAGCCGACCTCTTCAGTTCGTACCCTCTACCACCCAGACATGGACTGGTTTGCGAAATTCTCCATCAACGTACGATTAACCAATTGCGTGCGCAAAAACGCGTGGTACGAACTCGACAGCGCCGTGCAGCTCACGTCGATTCTCAAACCGATTCGAGAAAACGAACAGCTGCACAATCCTGTATTTAAAGTGATGACAGAGCCTTACGCCACCACGTTGAATCTAGAAAGTGTCGCTGAGCGTAATTGGGACGACAACACCAAAGCGCGCGAATCGTTTGGGATTTTGTATCGCGAAAATTTCTCGCTGAGCGAAGTCGATATCTTAAAACCAACCCTCGCTGGCGCTCTGTTTGCATACGACAAAAACGGCGACAGTTGCATTGCTCAACGCCTTAAAAACAAAGCGCGTACTACGCAAATTCGCTATTCCGACATCGCGACACTGTGGTTTGAACGCTATTTGCATTGCCTGATCCCGGGCGTGTTTAATTACTACTTCAAACACGGAGTGGCGTTTGAGCCGCATTTGCAAAACACCTTGATTGGCTTTGAGCAAGAGATGCCGTGTTGTGTTTGGATTCGTGATTTGGAAGGCACCAAGTTACTGCCGGAGTTTTGGCCAGCAGAAACATTAACTGACTTGTCTGAACGCGCGCGACAATCGGTTTACTACAGTCGCGAACAAGGCTGGAATCGCATCGGATACTGCACCTTTATCAACAACATCAGCGAAGCGATTTTCTTCATCGCAGAAGGTGATGAGCCACTAGAGCAAACGCTGTGGAATGCGGTGCAAAGTGCCATTGTGCGTTGGCAGTCAGTGAATGGAAAACAGCCAGAACTAGAAGCATTGCTGAATGGCGGTCACTTCCCAAGCAAAAATAATTTCACCACACGTTTGATGCAAAAAGCCGATAAAGAGTCGGGCTATACCCAAGTCTCCGCGCCTTGGCAGCAACACGAAAAAGGAGCGCAACATGTCTAA	MLQTQSSQTSELRAHDVQLNREKAQLNTIMGVLNCYLREFALPNQQVEWHYQSTSLPQTLKRNYSAKQRVAVHLSQQNGVLVLPIHYASKLGKIKLAELPWAKMPGSGWAKLDATQTLTLLLNYLKQVLAIPFNHELIEQLENSVLVTEQFLNVASKSHHNEFIASEQSLIWGHTFHPTPKSRSGVTMDDLLAFSPEVGAQVPLYWFEVDTSLLDVLNSDGDANPAQRMLQQLAPQHATSNGKTLYPCHPWESYTILSNPSVKAPIEQGKITPLGLGGEKMQPTSSVRTLYHPDMDWFAKFSINVRLTNCVRKNAWYELDSAVQLTSILKPIRENEQLHNPVFKVMTEPYATTLNLESVAERNWDDNTKARESFGILYRENFSLSEVDILKPTLAGALFAYDKNGDSCIAQRLKNKARTTQIRYSDIATLWFERYLHCLIPGVFNYYFKHGVAFEPHLQNTLIGFEQEMPCCVWIRDLEGTKLLPEFWPAETLTDLSERARQSVYYSREQGWNRIGYCTFINNISEAIFFIAEGDEPLEQTLWNAVQSAIVRWQSVNGKQPELEALLNGGHFPSKNNFTTRLMQKADKESGYTQVSAPWQQHEKGAQHV	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	245.56	gnl|BL_ORD_ID|1424|hsp_num:0	1549			171	279	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000946.1|Vibrioferrin_5 # 6329 # 7531 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.504	BGC0000946.1|Vibrioferrin_5 	6329	7531	+	Loose	200	27.7202	vanT gene in vanE cluster	33.33	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTCTAATTCACTCTCCCTACCCACACGCGTTAGCCAGCAAGTTCACACGCTCGCACAGCAGCAAAATCAACCCTTGTGCGCGTACTTGTATGACCTAAACGCCTTAGAAGAACACATCAAACAACTGCGTCACGTTTTGCCGAAAAATGTCAAGCTATTTTACGCAGCCAAAGCCAATCCATCGGGCCCGATTCTCAACACGCTCGCGCCGTATGTCGATGGTTTTGAAGCGGCGTCTGGCGGGGAGTTGACACACCTCCACCAGCAACAACTCGATAAGCCATTGATCTTCGGTGGCCCAGGGAAAATGCCAAGTGAATTGCAACAAGCGATTGAGCTGGATGTCGATGCGATTCATGTCGAAAGCCTCACCGAGCTGCAACGGATTGGTGCGCTAACCGAGCGCCTTAACCGCCCTGCTTCGATCTTTTTGCGTATGAACATCGATATTGGCGACATCACGCTCAGCAAGTTGGCAATGGGCGGCAAGCCGACTCCTTTTGGTTTGGACGAGTCCGAACTGAGTAATGCTTTGATGTTGCTGCGCGATTTCCCGCAAGTGTCGCTGAAAGGTTTCCATTTTCACTTGATGTCGCATCAGCTCGATGTTGAACGTCACTTAGCGTTAATGCAGCGCTATTTCCAAGTCGTGAAGGCGTGGCAACAAGAGTTTGAACTCGGTGAGCTGATGATCAACTTGGGTGGAGGCATGGGGATTAACTACCAAAACCCTGAGCAACACTTTCCGTGGATGGAGTTTTGCGACAAGTTGGAATTCCTCATCGCCAAAGAGCAAGTGCAAGACTGGACACTGCGTTTTGAATGCGGACGTTTCATCACGGCGGCATGCGGTTACTACGTAATGGAAGTGCTGGATATTAAGCAAAATCTTGGCGAAAACTTTGTCATCGCGCGCGGAGGAACTCACCACTTCCGCACGCCAGCAGCGCAGAGTCATGACCATCCATTCGTCATCCTGAAAAGCGAGCAACACCATGATATTTCTCATCCAATTCAGCATGCACAAGCGACCTTTGTCGGCCAGCTTTGTACGCCCAAAGATGTGCTGGCACGCAATCAACACGTCGCCCACGTCGATATTGGTGATTACGTTGTGTTTACCTTAGCGGGCGCCTATGCGTGGAACATCTCCCATCAAAACTTCTTGATGCATGAACCGCCGATCTTCCACTATTTCTAA	MSNSLSLPTRVSQQVHTLAQQQNQPLCAYLYDLNALEEHIKQLRHVLPKNVKLFYAAKANPSGPILNTLAPYVDGFEAASGGELTHLHQQQLDKPLIFGGPGKMPSELQQAIELDVDAIHVESLTELQRIGALTERLNRPASIFLRMNIDIGDITLSKLAMGGKPTPFGLDESELSNALMLLRDFPQVSLKGFHFHLMSHQLDVERHLALMQRYFQVVKAWQQEFELGELMINLGGGMGINYQNPEQHFPWMEFCDKLEFLIAKEQVQDWTLRFECGRFITAACGYYVMEVLDIKQNLGENFVIARGGTHHFRTPAAQSHDHPFVILKSEQHHDISHPIQHAQATFVGQLCTPKDVLARNQHVAHVDIGDYVVFTLAGAYAWNISHQNFLMHEPPIFHYF	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	56.98	gnl|BL_ORD_ID|4680|hsp_num:0	1308			1050	1140	vancomycin
BGC0000946.1|Vibrioferrin_6 # 7606 # 7734 # -1 # ID=1_6;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.473	BGC0000946.1|Vibrioferrin_6 	7606	7734	-	Loose	700	22.3274	ACT-64	47.37	3006259	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	GATTCGATGGCGGTCAATCCGGTTGCCCAGCAAGCGATAAACTCGGAAATCTTCCGTTTTTACCGCAATCCCAAGCTGGAACCCGACGAGCTGATAAAACGCATTATTGCTATTTCGCAAAGCGGTTAA	DSMAVNPVAQQAINSEIFRFYRNPKLEPDELIKRIIAISQSG	MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGHPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQDWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEQAMTKRVFKPLKLDHTWIDVPKEDEAHYAWGYRDGKTVHVSPGMLDAEAYGVKTNVQDMASWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSALQ	11.02	gnl|BL_ORD_ID|3117|hsp_num:0	4155			774	831	
